A randomized, double-blind, placebo-controlled trial to evaluate the efficacy, safety, tolerability, and pharmacokinetic/pharmacodynamic effects of a targeted exposure of intravenous repinotan in patients with acute ischemic stroke: modified Randomized Exposure Controlled Trial (mRECT) - Teal, Philip; Hacke, Werner; Hennerici, Michael G. (Stroke, 2009)
Gesehen am 21.11.2014
Advisory board: A. Davalos, Girona, Spain; L. B. Goldstein, Durham, NC; D. F. Hanley, Baltimore, Md; M. Hennerici, Mannheim, Germany; G. L. Lenzi, Rome, Italy; J. M. Orgogozo, Bordeaux, France; R. Sacco, New York, NY